RRx-001 Completed Phase 2 Trials for Oral Mucositis Supportive Care

Indications	Status	Purpose	Phase
DBCOND0031602 (Oral Mucositis)	Completed	Supportive Care	2

clinicaltrials.gov Identifier	Title	Drugs
NCT03515538	Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers	Cisplatin (DB00515) RRx-001 (DB12060)